Arterys Inc., a San Francisco, CA-based provider of an AI platform for medical image analytics, closed its $30M Series B financing round.
The investment was led by Temasek, strategic investors Northwell Health Ventures, NewYork-Presbyterian, Varian Medical Systems and GE Ventures, and joined by Fosun, DNA Capital, Emergent Medical Partners, and ORI Capital.
The company plans to use the funding to expand its web-based artificial intelligence platform, and launch several products in oncology and neurology, and to accelerate the commercialization of its cardiac offering.
Led by Fabien Beckers, PhD, founder and CEO, Arterys has created a web based platform for medical image analytics that enables physicians to benefit from vast amounts of computation, process their patient cases with support from AI algorithms that are embedded in their workflow. The proprietary technology protects patient information and complies with data privacy regulations in the U.S. and EU.
The cloud platform supports a variety of imaging modalities, such as MRI and CT, providing image interpretation with artificial intelligence tools, case sharing, and automated reporting.
The company’s Cardiac MRI, the first product of its kind to obtain FDA clearance for use as a diagnostic support tool, is cleared in Canada and the EU. The platform and cardiac MRI suite have been used to help diagnose more than 15,000 patients worldwide, in many cases leading to more informed clinical diagnoses and treatment decisions.